Adaptive biotech Corp Live Stock Price Today, Share Analysis and Chart

Name: Adaptive Biotechnologies Corp: Is Infosys Ltd. worth buying?
Item: Adaptive Biotechnologies Corp
Rating: 1.275874875
Author: Trendlyne DVM scores

Weak Stock

about

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, ...

27.86 -0.75 (-2.62%)

69.45% Fall from 52W High

1.5M

XNAS Volume

XNAS 21 Sep, 2026 5:30 PM (EDT)

Low Financial Strength

33.3 / 100

Expensive Valuation

6.8 / 100

Technically Bearish

28.6 / 100

Weak Stock These stocks have poor scores across the board. Investors should be very cautious with these stocks View Similar Embed DVM

1Yr Price target downside is -10%

7 analysts

Adaptive biotech Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Adaptive biotech Corp Live Stock Price Today, Share Analysis and Chart

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, ...

69.45% Fall from 52W High

SWOT Analysis

Adaptive biotech Corp Live Price Chart

Adaptive biotech Corp Live Price Chart